无创正压通气治疗慢性阻塞性肺疾病合并呼吸衰竭的疗效预测因素研究进展  

Research progress of effectiveness predictive factors in noninvasive positive pressure ventilation treatment of chronic obstructive pulmonary disease with respiratory failure

作　　者：王中超[1] 王海峰[1] 王明航[1] 李素云[1] 

机构地区：[1]河南中医学院第一附属医院呼吸科,郑州450000

出　　处：《国际呼吸杂志》2013年第5期370-373,共4页International Journal of Respiration

基　　金：2010年度河南省科技创新人才项目（104200510004）;郑州市科技领军人才项目（10LJRC172）

摘　　要：近年来无创正压通气（NIPPV）被广泛应用于临床，已作为慢性阻塞性肺疾病（COPD）合并呼吸衰竭的首选治疗手段，具有痛苦少、无创性、易接受等优点。但临床上有些患者因为应用NIPPV治疗而错过了有创呼吸机或气管插管治疗的最佳时机。因此，如何在适当的时候选择应用NIPPV对COPD合并呼吸衰竭患者至关重要。该篇文章主要从COPD合并呼吸衰竭的疗效相关预测因素进行综述，以便为l临床医师选择NIPPV治疗COPD合并呼吸衰竭提供参考。Recent years, noninvasive positive pressure ventilation （NIPPV） which was the preferred management for COPD patients with respiratory failure had been widely used in clinical treatment. This noninvasive therapy brought the patients less sufferings who liefly accepted it. But some patients who had received NIPPV missed the best time for the invasive ventilator treatment or intubation. Therefore,it was critical to the COPD patients with respiratory failure that applying NIPPV at the proper time. This review mainly discoursed on effectiveness predictive factors in NIPPV treatment of COPD patients with respiratory failure which was intended to provide evidence for the clinician to adopt NIPPV.

关 键 词：无创正压通气 慢性阻塞性肺疾病 呼吸衰竭 预测因素 

分 类 号：R563.9[医药卫生—呼吸系统]